167 related articles for article (PubMed ID: 38496757)
61. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
62. Long-term results of first-line sequential high-dose carboplatin, etoposide and ifosfamide chemotherapy with peripheral blood stem cell support for patients with advanced testicular germ cell tumor.
Miki T; Mizutani Y; Akaza H; Ozono S; Tsukamoto T; Terachi T; Naito K; Nonomura N; Hara I; Yoshida O;
Int J Urol; 2007 Jan; 14(1):54-9. PubMed ID: 17199861
[TBL] [Abstract][Full Text] [Related]
63. Promising novel therapies for relapsed and refractory testicular germ cell tumors.
Kozakova K; Mego M; Cheng L; Chovanec M
Expert Rev Anticancer Ther; 2021 Jan; 21(1):53-69. PubMed ID: 33138660
[TBL] [Abstract][Full Text] [Related]
64. Relevance of Comet Assay and Phosphorylated-Hsp90α in Cancer Patients' Peripheral Blood Leukocytes as Tools to Assess Cisplatin-based Chemotherapy Clinical Response and Disease Outcome.
Sottile ML; Gómez LC; Redondo A; Ibarra J; García MB; Gonzalez L; Vargas-Roig LM; Nadin SB
J Histochem Cytochem; 2024 Mar; 72(3):173-188. PubMed ID: 38439738
[TBL] [Abstract][Full Text] [Related]
65. A Suggested Prognostic Reclassification of Intermediate and Poor-Risk Nonseminomatous Germ Cell Tumors.
Necchi A; Pond GR; Nicolai N; Giannatempo P; Raggi D; Adra N; Hanna NH; Salvioni R; Einhorn LH; Albany C
Clin Genitourin Cancer; 2017 Apr; 15(2):306-312.e3. PubMed ID: 27594554
[TBL] [Abstract][Full Text] [Related]
66. MAPK15 upregulation promotes cell proliferation and prevents DNA damage in male germ cell tumors.
Rossi M; Colecchia D; Ilardi G; Acunzo M; Nigita G; Sasdelli F; Celetti A; Strambi A; Staibano S; Croce CM; Chiariello M
Oncotarget; 2016 Apr; 7(15):20981-98. PubMed ID: 26988910
[TBL] [Abstract][Full Text] [Related]
67. The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.
De Giorgi U; Rosti G; Papiani G; Marangolo M
Haematologica; 2002 Jan; 87(1):95-104. PubMed ID: 11801470
[TBL] [Abstract][Full Text] [Related]
68. High-dose chemotherapy followed by hematological support: experience in the treatment of germ cell tumors.
Pico JL; Fadel E; Ibrahim A; Bourhis JH; Droz JP
Bull Cancer; 1995; 82 Suppl 1():56s-60s. PubMed ID: 7542945
[TBL] [Abstract][Full Text] [Related]
69. Overcoming Chemotherapy Resistance in Germ Cell Tumors.
Országhová Z; Kalavska K; Mego M; Chovanec M
Biomedicines; 2022 Apr; 10(5):. PubMed ID: 35625709
[TBL] [Abstract][Full Text] [Related]
70. Pathologic findings and clinical outcomes in patients who required neoadjuvant chemotherapy before orchiectomy for testicular germ cell tumors.
Stump JA; Acosta AM; Whaley RD; Cheng L; Fang AM; Rais-Bahrami S; Gordetsky JB
Hum Pathol; 2022 Oct; 128():48-55. PubMed ID: 35817140
[TBL] [Abstract][Full Text] [Related]
71. Assessment of chemotherapy-induced DNA damage in peripheral blood leukocytes of cancer patients using the alkaline comet assay.
Kopjar N; Garaj-Vrhovac V; Milas I
Teratog Carcinog Mutagen; 2002; 22(1):13-30. PubMed ID: 11754384
[TBL] [Abstract][Full Text] [Related]
72. Long-term biomonitoring of breast cancer patients under adjuvant chemotherapy: the comet assay as a possible predictive factor.
Uriol E; Sierra M; Comendador MA; Fra J; Martínez-Camblor P; Lacave AJ; Sierra LM
Mutagenesis; 2013 Jan; 28(1):39-48. PubMed ID: 22987025
[TBL] [Abstract][Full Text] [Related]
73. Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors.
Motzer RJ; Mazumdar M; Gulati SC; Bajorin DF; Lyn P; Vlamis V; Bosl GJ
J Natl Cancer Inst; 1993 Nov; 85(22):1828-35. PubMed ID: 7693955
[TBL] [Abstract][Full Text] [Related]
74. Current aspects of high-dose chemotherapy in germ-cell tumors.
Rick O; Kollmannsberger C; Beyer J; Bokemeyer C
Crit Rev Oncol Hematol; 2003 Sep; 47(3):237-48. PubMed ID: 12962898
[TBL] [Abstract][Full Text] [Related]
75. Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumours.
Fosså SD; Stenning SP; Gerl A; Horwich A; Clark PI; Wilkinson PM; Jones WG; Williams MV; Oliver RT; Newlands ES; Mead GM; Cullen MH; Kaye SB; Rustin GJ; Cook PA
Br J Cancer; 1999 Jul; 80(9):1392-9. PubMed ID: 10424741
[TBL] [Abstract][Full Text] [Related]
76. Surgical treatment confers prognostic significance in pediatric malignant mediastinal germ cell tumors.
Huang TH; Hung GY; Weng TF; Wang FM; Lee CY; Lin DT; Chen BW; Lin KH; Wu KH; Liu HC; Chen JS; Jou ST; Hou JY; Yang YL; Chen SH; Chang HH; Chiou SS; Lin PC; Chen RL; Hsiao CC; Yen HJ; Yang CP; Chang TK; Lu MY; Cheng CN; Sheen JM; Liao YM; Su MY; Yeh TC;
Cancer; 2022 Dec; 128(23):4139-4149. PubMed ID: 36223226
[TBL] [Abstract][Full Text] [Related]
77. Primary mediastinal germ cell tumors in children and adolescents: results of the German cooperative protocols MAKEI 83/86, 89, and 96.
Schneider DT; Calaminus G; Reinhard H; Gutjahr P; Kremens B; Harms D; Göbel U
J Clin Oncol; 2000 Feb; 18(4):832-9. PubMed ID: 10673525
[TBL] [Abstract][Full Text] [Related]
78. Risk of residual cancer after complete response following first-line chemotherapy in men with metastatic non-seminomatous germ cell tumour and International Germ Cell Cancer Cooperative Group intermediate/poor prognosis: A multi-institutional retrospective cohort study.
Antonelli L; Ardizzone D; Ravi P; Bagrodia A; Mego M; Daneshmand S; Nicolai N; Nazzani S; Giannatempo P; Franza A; Heidenreich A; Paffenholz P; Saoud R; Eggener S; Ho M; Oswald N; Olson K; Tryakin A; Fedyanin M; Naoun N; Javaud C; Fizazi K; King JM; Adra N; Douglawi A; Cary C; Sweeney C; Fankhauser CD
Eur J Cancer; 2023 Mar; 182():144-154. PubMed ID: 36787661
[TBL] [Abstract][Full Text] [Related]
79. Late Relapse of Germ Cell Tumors After Prior Chemotherapy or Surgery-only.
Richardson NH; Althouse SK; Ashkar R; Cary C; Masterson T; Foster RS; Einhorn LH; Adra N
Clin Genitourin Cancer; 2023 Aug; 21(4):467-474. PubMed ID: 37088659
[TBL] [Abstract][Full Text] [Related]
80. Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor.
Kurobe M; Kawai K; Oikawa T; Ichioka D; Kandori S; Takaoka E; Kojima T; Joraku A; Suetomi T; Miyazaki J; Nishiyama H
J Cancer Res Clin Oncol; 2015 Jan; 141(1):127-33. PubMed ID: 25062721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]